adenine has been researched along with alvocidib in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brandsen, J; de Azevedo Júnior, WF; Kim, SH; Schulze-Gahmen, U | 1 |
| Barnes, G; Espinoza, FH; Gray, NS; Kim, SH; Kwon, S; LeClerc, S; Lockhart, DJ; Meijer, L; Morgan, DO; Norman, TC; Schultz, PG; Thunnissen, AM; Wodicka, L | 1 |
| Détivaud, L; Doerig, C; Gray, N; Meijer, L | 1 |
| Abdul-Hay, M; Desai, AV; El-Bakkar, H | 1 |
2 review(s) available for adenine and alvocidib
| Article | Year |
|---|---|
ATP-site directed inhibitors of cyclin-dependent kinases.
Topics: Adenine; Adenosine Triphosphate; Amino Acid Sequence; Antineoplastic Agents; Binding Sites; Cell Cycle; Cyclin-Dependent Kinases; Drug Design; Enzyme Inhibitors; Flavonoids; Humans; Isopentenyladenosine; Kinetin; Molecular Sequence Data; Piperidines; Purines; Roscovitine; Sequence Alignment; Sequence Homology, Amino Acid; Staurosporine; Suramin | 1999 |
Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future.
Topics: Adenine; Aniline Compounds; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Flavonoids; Humans; Immunologic Factors; Indolizines; Isoquinolines; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Purines; Pyrazoles; Pyridinium Compounds; Pyrimidines; Quinazolinones; Receptors, Antigen, T-Cell; Sulfonamides; Thalidomide | 2015 |
3 other study(ies) available for adenine and alvocidib
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structural basis for chemical inhibition of CDK2.
Topics: Adenine; Adenosine Triphosphate; Animals; Binding Sites; CDC2-CDC28 Kinases; Cell Cycle; Crystallography, X-Ray; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Isopentenyladenosine; Kinetin; Ligands; Macromolecular Substances; Models, Molecular; Piperidines; Protein Conformation; Protein Serine-Threonine Kinases; Purines; Recombinant Proteins | 1996 |
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.
Topics: Adenine; Binding Sites; CDC2-CDC28 Kinases; CDC28 Protein Kinase, S cerevisiae; Cell Division; Crystallography, X-Ray; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Drug Evaluation, Preclinical; Flavonoids; Gene Expression Regulation, Fungal; Genes, Fungal; Humans; Hydrogen Bonding; Oligonucleotide Probes; Phosphates; Piperidines; Protein Serine-Threonine Kinases; Purines; RNA, Messenger; Saccharomyces cerevisiae; Structure-Activity Relationship; Transcription, Genetic; Tumor Cells, Cultured | 1998 |